We’re pleased to invite you to a short seminar
Date: Wednesday, July 23rd, 2025
Time: 08:30–13:00
Location: Alon Hall, IMP Facility (SLE), Hate’ena 1 st., Modiin Region Industrial Park
Waze: סלא טבע שוהם

Join us for a focused and insightful seminar exploring the evolving landscape of vendor management in clinical trials — from oversight to strategic collaboration, from building networks to maximizing local advantages.

Agenda

08:30–09:00 Registration & Coffee
09:00–09:15 Opening Remarks
Limor Teomim, CEO, IMP
09:15–09:45 Introduction to the Service Providers Community 
Roy Zaibel
Co-CEO, ADRES
09:45–10:15 Sponsor Oversight According to ICH E6
Rivka Zaibel, President and Founder, ADRES
10:15–10:45 From Selection to Partnership: Strategic Collaboration in Clinical Supply Management
Limor Teomim, CEO, IMP
10:45–11:15 Coffee Break
11:15–11:45 Laying the Foundation: How a Growing Sponsor Built Its Vendor Network
Donna Ehrenberg, VP Clinical Operations, Elgan Pharma
11:45–12:15 Vendor Risk and Oversight: Balancing Speed with Compliance
Sofi Glam, VP Business Development & Customer Success, IMP
12:15–12:45 Panel: Vendor Decisions: Choosing, Managing, Collaborating
Moderator: Limor Teomim, CEO, IMP
Sofi Glam, VP Business Development & Customer Success, IMP
Donna Ehrenberg, VP Clinical Operations, Elgan Pharma
Noga Brunicki, Owner, NovaTrials – Clinical Research Organization
12:45–13:00 Closing Remarks
Intended audience:
Companies, startups, and professionals involved in the planning, execution, or support of clinical trials — including (bio)pharmaceutical and medical device innovators at or approaching a clinical stage, as well as CROs, service providers, and clinical operations teams seeking to optimize vendor collaboration.

Free of charge for IMP customers
For participants that are not yet clients of IMP
the price per participant is 480 NIS + VAT

Registration is mandatory and will be pre-approved

Up to 2 participants per company. Additional participants require payment in full

 

Share this article

From Contract to Collaboration: Navigating Vendor Management in Clinical Trials

Blog
Risk Management and Vendor Partnerships in Clinical Trials Logistics: Building Resilient Supply Chains

In clinical trials, logistics are the invisible backbone. From investigational medicinal products (IMPs) and ancillary supplies to temperature-controlled storage and timely distribution, each element must function with precision. But what happens when a link in the chain breaks? Supply chain disruptions—caused by global events, vendor failures, regulatory hurdles, or logistical delays—can jeopardize timelines, budgets, and, […]

Blog
Navigating 29C Importation in Israel

What is 29C Importation? Regulation 29C governs the importation of non-registered medicinal products into Israel under specific conditions. This regulation allows hospitals, healthcare providers, and sponsors to access treatments that are not locally registered but are essential for patient care. These imports often support clinical trials, compassionate use programs, or off-label treatments when no registered […]

Blog
Navigating Importation Regulations for Clinical Trials

Importing Investigational Medicinal Products (IMPs) and medical supplies for clinical trials is a complex and highly regulated process. Unlike standard commercial imports, clinical trial importation involves unique regulatory and logistical challenges that require specialized expertise. At IMP, we ensure a seamless and compliant importation process, working closely with regulatory authorities, customs officials, and shipping providers […]

Contact Us

    Back to top